{"url_path":"/sec/cnsp/10-q/2026/body","section_key":"body","section_title":"Body","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1729427/0001683168-26-003847-index.html","accession_number":"0001683168-26-003847","cik":"0001729427","ticker":"CNSP","issuer_name":"CNS Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1729427/0001683168-26-003847-index.html","primary_entity_key":"0001729427","primary_entity_name":"CNS Pharmaceuticals, Inc."},"word_count":495,"has_tables":false,"body_markdown":"EX-31.1\n2\ncns_ex3101.htm\nCERTIFICATION\n\n**Exhibit 31.1**\n\n**CERTIFICATION BY CHIEF EXECUTIVE OFFICER**\n\nI, Rami Levin, certify that:\n\n1. I have reviewed this quarterly report on Form\n10-Q of CNS Pharmaceuticals, Inc.;\n\n2. Based on my knowledge, this report does not\ncontain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the\ncircumstances under which such statements were made, not misleading with respect to the period covered by this report;\n\n3. Based on my knowledge, the financial statements,\nand other financial information included in this report, fairly present in all material respects the financial condition, results of operations\nand cash flows of the registrant as of, and for, the periods presented in this report;\n\n4. The registrant’s other certifying officer\nand I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)\nand 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant\nand we have:\n\na. designed such disclosure controls and procedures,\nor caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to\nthe registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the\nperiod in which this report is being prepared;\n\nb. designed such internal control over financial\nreporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance\nregarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with\ngenerally accepted accounting principles;\n\nc. evaluated the effectiveness of the registrant’s\ndisclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and\nprocedures, as of the end of the period covered by this report based on such evaluation; and\n\nd. disclosed in this report any change in the registrant’s\ninternal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s\nfourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the\nregistrant’s internal control over financial reporting; and\n\n5. The registrant’s other certifying officer\nand I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors\nand the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):\n\na. all significant deficiencies and material weaknesses\nin the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s\nability to record, process, summarize and report financial information; and\n\nb. any fraud, whether or not material, that involves\nmanagement or other employees who have a significant role in the registrant’s internal control over financial reporting.\n\nMay 14, 2026\n\nBy: /s/ Rami Levin\n\nRami Levin\n\nChief Executive Officer, President\n\n(Principal Executive Officer)\n\n** **"}